Garry, Glynnis A. http://orcid.org/0000-0002-3777-0151
Bezprozvannaya, Svetlana
Chen, Kenian http://orcid.org/0000-0002-4083-841X
Zhou, Huanyu
Hashimoto, Hisayuki
Morales, Maria Gabriela
Liu, Ning http://orcid.org/0000-0003-0257-1889
Bassel-Duby, Rhonda http://orcid.org/0000-0001-7568-410X
Olson, Eric N. http://orcid.org/0000-0003-1151-8262
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (5T32HL125247, HL-138426, HD-087351, HL-130253, HL-130253, HD-087351)
American Heart Association (14PRE20030030)
Uehara Memorial Foundation
Kanae Foreign Study Grant
Pew Charitable Trusts
Fondation Leducq
Welch Foundation (1-0025)
Robert A. Welch Foundation (grant 1-0025); Foundation Leducq Transatlantic Networks of Excellence in Cardiovascular Research
Article History
Received: 12 June 2020
Accepted: 23 March 2021
First Online: 3 May 2021
Competing interests
: E.N.O. is a co-founder and member of the Scientific Advisory Board of Tenaya Therapeutics and holds equity in the company. The other authors declare no competing interests.